<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00662376</url>
  </required_header>
  <id_info>
    <org_study_id>N-POB-01-UK</org_study_id>
    <nct_id>NCT00662376</nct_id>
  </id_info>
  <brief_title>Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder Surgery</brief_title>
  <official_title>Safety, Tolerance and Metabolic Effects of Using a Preoperative Oral Nutritional Supplement (PreOP Booster) in Gastrointestinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi</source>
  <brief_summary>
    <textblock>
      The aim of this pilot study is to obtain data on the safety, tolerance and metabolic effects
      of the oral nutritional supplement (PreOP Booster) given to patients prior to
      gastrointestinal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety parameters reflecting pathophysiological functions of the liver</measure>
    <time_frame>day -1, 0, 1, and 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastrointestinal tolerance</measure>
    <time_frame>day 0 before and 6-8h after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Metabolic parameters in serum, liver and muscle tissue</measure>
    <time_frame>on day -1, 0, 1, and 7</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical parameters (infectious and non-infectious complications)</measure>
    <time_frame>until day 7</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Enteral Nutrition Regimen Prior to Surgery</condition>
  <arm_group>
    <arm_group_label>Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral nutritional supplement (assignment: according to consecutive random numbers)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo (assignment: according to consecutive random numbers)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PreOP Booster (oral nutritional supplement, food for special medical purposes)</intervention_name>
    <description>3 x 1 dosages of oral nutritional supplement / placebo are given prior to surgery: 2 the evening before the day of operation and 1 dosage 3-4 h before initiation of anaesthesia</description>
    <arm_group_label>Test</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective laparoscopic cholecystectomy

        Exclusion Criteria:

          -  bile duct stones

          -  ileus

          -  conditions affecting gastric emptying

          -  severe, organ-specific disorders

          -  HIV

          -  inherited metabolic disorders

          -  known intolerance against or allergy to any component of the investigational feeds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dileep N. Lobo, MS, DM, FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Queen's Medical Centre, Division of Gastrointestinal Surgery, Nottingham University Hospitals;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen's Medical Centre, Division of Gastrointestinal Surgery, Nottingham University Hospitals;</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2008</study_first_submitted>
  <study_first_submitted_qc>April 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2008</study_first_posted>
  <last_update_submitted>December 5, 2008</last_update_submitted>
  <last_update_submitted_qc>December 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Steffen Benzing</name_title>
    <organization>Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

